Vistin Pharma - Earnings Release 2023

Vistin Pharma ASA: Invitation to Q1 2023 conference call

Oslo, Norway, 20 April 2023

Vistin Pharma ASA will release its first quarter 2023 results on Thursday 27(th)

of April 2023. Vistin Pharma will host a conference call for all shareholders

and interested parties at the same day: Thursday 27(th) of April at 08:30 CET.

There will be a Q&A session following the management discussion.

The conference call will be held in English.

The first quarter conference call will be available via web and audio through

the following access points:

Webcast:

https://edge.media-server.com/mmc/p/esnqd8k9

(https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fedge.media-

server.com%2Fmmc%2Fp%2Fesnqd8k9&data=05%7C01%7CAlexander.Karlsen%40vistin.com%7C

e1282fd245eb4cfda0c808db26cf9f51%7C2fcdf060b2c2456e8bb7944b7e40981a%7C0%7C0%7C63

8146445423803497%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJ

BTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=T9eI3Bw2LaVlhTp3jfALgSxf%2FVbY

LMRPGjyScLcQXGQ%3D&reserved=0)

Telephone conference (online registration):

https://register.vevent.com/register/BI27373abc81d0427486bb885a935c342c

*****

For further information, please contact:

Alexander Karlsen

CFO

+47 97053621

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin

Hydrochloride (API). The Metformin is also available as Direct Compressible

lubricated granules. As a solely dedicated European Metformin producer, Vistin

Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin

Pharma is headquartered in Oslo, Norway, and has highly qualified employees and

a dedicated manufacturing facility in Kragerø.

AI assistant